B. Shrestha

Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study

J. Kosterink, D. Touw, J. Alffenaar, 2020, BMJ open respiratory research.

Genetic diversity and distribution dynamics of multidrug-resistant Mycobacterium tuberculosis isolates in Nepal

S. Gordon, C. Nakajima, Yasuhiko Suzuki, 2018, Scientific Reports.

Risk of relapse and failure after retreatment with the Category II regimen in Nepal.

T. Yoshiyama, B. Maharjan, B. Shrestha, 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Evaluation of saliva as a potential alternative sampling matrix for therapeutic drug monitoring of levofloxacin in MDR-TB patients

J. Kosterink, D. Touw, C. Jan-Willem, 2019 .

Evaluation of Saliva as a Potential Alternative Sampling Matrix for Therapeutic Drug Monitoring of Levofloxacin in Patients with Multidrug-Resistant Tuberculosis

J. Kosterink, D. Touw, J. Alffenaar, 2019, Antimicrobial Agents and Chemotherapy.

A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.

D. Mitchison, T. Harrison, G. Borgulya, 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Ambulatory-Based Standardized Therapy for Multi-Drug Resistant Tuberculosis: Experience from Nepal, 2005–2006

K. Feldmann, D. Falzon, M. Akhtar, 2009, PLoS ONE.

Genetic diversity and distribution dynamics of multidrug-resistant Mycobacterium tuberculosis isolates in Nepal

S. Gordon, C. Nakajima, Yasuhiko Suzuki, 2018, Scientific Reports.

Rapid Tuberculosis diagnostics including molecular first- and second-line resistance testing based on a novel microfluidic DNA extraction cartridge.

N. Paust, Vera Allerheiligen, Martin Eckart, 2021, The Journal of molecular diagnostics : JMD.

Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients

J. Kosterink, D. Touw, J. Alffenaar, 2019, European Respiratory Journal.

Levofloxacin pharmacokinetics and pharmacodynamics and outcome in MDR-TB patients

J. Kosterink, D. Touw, C. Jan-Willem, 2019 .